Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy-Reference-Cited by-同舟云学术

Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy

Published:2018-07 Issue:4 Volume:19 Page:e399-e404
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Zheng Ye,Shi Anhui,Wang Weihu,Yu Huiming,Yu Rong,Li Dongming,Xu Bo,Ma Huimin,You Jing,Zhao Dan,Jiang Leilei,Geng Jianhao,Zhu Guangying

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Surgery for early stage non–small cell lung cancer;Chang;Semin Surg Oncol,2003

2. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study;Onishi;Cancer,2004

3. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer;Timmerman;J Clin Oncol,2006

4. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiation therapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

5. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non–small cell lung cancer;Chang;Int J Radiat Oncol Biol Phys,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control;Radiotherapy and Oncology;2024-02

2. Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers;Radiation Oncology Journal;2023-03-31

3. Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination;Journal for ImmunoTherapy of Cancer;2022-10

4. The prognostic value of circulating lymphocyte counts and ABO blood group in lung cancer stereotactic body radiation therapy: a retrospective study;Journal of Thoracic Disease;2022-02

5. Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors;Journal of Inflammation Research;2021-08